Science Current Events | Science News | Brightsurf.com
 

Liver Cirrhosis Current Events | Liver Cirrhosis News | 9

Sort By: Page Views | Date

What are the risk factors for rebleeding after negative angiography?
Acute non-variceal gastrointestinal bleeding accounts for approximately 20% of emergency room visits and 5% of admissions.   view more (2009-09-16)

HIV positive and HIV negative patients have similar survival rates following liver transplant
HIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark.   view more (2009-04-24)

The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts
As part of an effort to develop effective medical therapies that block the progression of liver cyst growth in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), researchers at the University of Colorado Anschutz Medical Center have found that the liver cyst walls develop and maintain a vasculature as they grow out from the body... view more... (2009-09-24)

Portal vein thrombosis is common in extraportal vein obstruction
Among the 118 patients with portal vein thrombosis, noncirrhotic and nontumoral extrahepatic portal vein obstruction are young and present with well tolerated bleed.   view more (2007-10-15)

DKK-3 and WIF-1: Proteins related to liver cancer development?
Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year.   view more (2009-06-15)

Vascular and biliary complications after liver transplant can be reliably diagnosed when using CE-US
Contrast-enhanced ultrasound (CE-US) after a liver transplant is highly accurate in showing vascular as well as biliary complications, according to a recent study.   view more (2007-05-07)

Non-steroidal anti-inflammatory drug increases liver damage in mice carrying mutant human gene
Alpha-1-antitrypsin deficiency isn't a term that rolls right off the tongue. But people diagnosed with this genetic disorder learn its potential effects well.   view more (2006-11-16)

Mild hepatitis C infection will rapidly worsen in one in three people affected
Mild hepatitis C infection will rapidly worsen in one in three of those affected, suggests research in Gut. This is particularly likely in those who are older when first infected, and those who already have a degree of inflammation and scar tissue (fibrosis) in their liver at diagnosis. The viral liver infection hepatitis C (HCV) is mainly passed... view more... (2004-02-11)

An alternative treatment for hypervascular hepatocellular carcinoma
HCC is the fifth most common cancer in the world and the third most frequent cause of cancer-related death. Only about 20% of HCC patients are eligible for surgical resection.   view more (2009-06-15)

Hepatitis C responds best to combo of ribavirin and interferon, study concludes
A combination of the drugs ribavirin and interferon is more effective in treating hepatitis C than using interferon alone, but it also increases the risk of side effects, according to a new systematic review of recent evidence.   view more (2005-07-20)

Fatty Liver a Possible Risk for Hypertension
The accumulation of fat in the liver, or "fatty liver," resulting from accumulation of central body fat, and perhaps not alcohol consumption, may represent an important underlying mechanism for the association between liver enzymes and hypertension.   view more (2005-11-03)

Parasite growth hormone pushes human cells to liver cancer
Scientists have found that the human liver fluke (Opisthorchis viverrini) contributes to the development of bile duct (liver) cancer by secreting granulin, a growth hormone that is known to cause uncontrolled growth of cells.   view more (2009-10-09)

Targeting the protein AEG1 impairs human liver cancer growth in mice
Hepatocellular carcinoma (HCC) is a highly aggressive form of liver cancer and one of the 5 most common cancers worldwide. Devanand Sarkar and colleagues, at Virginia Commonwealth University School of Medicine, Richmond, have now identified a gene that is expressed at high levels in human HCC tumor samples and generates a protein important for HCC... view more... (2009-02-17)

A rigorous method for liver biopsy
Liver biopsy is still considered the gold standard for grading, staging and "stad-ging" the chronic liver disease. In addition, it remains a primary source for acquiring new knowledge on the liver pathology.   view more (2009-01-05)

University of Sydney researchers find new evidence linking kava to liver damage
In recent years, serious concerns about the dangers of kava and the effects on the liver have resulted in regulatory agencies, such as the US Food and Drug Administration and Australia's Therapeutic Goods Administration, banning or restricting the sale of kava and kava products.   view more (2008-02-25)

Discovery could improve hepatitis C treatment
Walter and Eliza Hall Institute researchers are part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments.   view more (2009-09-24)

Are bone marrow mononuclear cells effective in reducing hepatic lesions?
Liver fibrosis occurs in the setting of chronic injury caused by different etiologies constituting a serious worldwide public health problem. In addition to schistosomiasis, hepatopathies due to alcohol, viral hepatitis, drugs, metabolic and autoimmune diseases, and congenital abnormalities are important causes of liver fibrosis.   view more (2008-10-24)

Early-onset obesity in father linked to increased potential for liver disease in child
A history of early-onset paternal obesity increases the odds of elevated liver enzyme levels in offspring and points to the potential for a genetic link between obesity and liver disease, according to a study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.   view more (2008-04-01)

Study shows no deeaths from living liver donors in Japan (pp 674, 687)
Issue 30 August 2003 Embargoed 0001 h (London time) 29 August 2003. Japanese research in this week's issue of THE LANCET highlights how liver donation from live donors-where part of a donor's liver is transplanted to a recipient-is not associated with mortality among donors, in contrast to this type of liver transplantation done in other parts... view more... (2003-08-27)

POOR PREDICTION OF OSTEOPOROSIS AFTER HEART OR LIVER TRANSPLANTATION (pp 325, 342)
The lack of identification of clear risk factors for osteoporotic fractures after organ transplantation reported in this week’s issue of THE LANCET suggests that future post-transplantation treatment should aim to prevent osteoporosis. Osteoporosis and related fractures are a major complication after organ transplantation. Gudrun... view more... (2001-01-31)
Sort By: Page Views | Date
© 2009 BrightSurf.com